Do implantable loop recorders impact the survival of patients with recurrent unexplained syncope?

• DOI: 10.2217/cer-2020-0242
• Publication Date: 2021-01-27T09:36:35Z
• Authors: Christian Perings; Claudia Wolff; Adrian Wilk; Andreas Witthohn; Rainer Voss; Karin Rybak
• Keywords: Implantable loop recorder; Charlson comorbidity index

Aim: This study compares the outcomes of patients who receive an implantable loop recorder (ILR) for unexplained syncope to a control group without diagnostic device in German claims data. Methods and materials: Patients with ILR were matched based on prior events, age, gender Charlson Comorbidity index (CCI). Survival, hospitalizations, treatment costs compared. Results/conclusion: Four hundred twelve controls, mean age was 68, CCI 2.7, 42% females. lived average 1.2 years longer than group. Twenty-five percent received therapeutic compared 5% ILRs might help diagnose treat positive impact survival.